Trial 3P-16-3


Phase IIa Trial Evaluating the Safety of Intratumoral Injection of NanoPac in Subjects with Locally Advanced Pancreatic Adenocarcinoma

Type: Treatment
Phase: Phase I/II
Status: Not Open (Closed)
Treatments: Other
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Jaques Van Dam, M.D.
Other Trial Staff:  Ramona Lujan, Coordinator, Raluca Agafitei, Coordinator, Marile Garcia, Coordinator, Melissa Wallman, Coordinator, Yanli Wang, D.M., Rabia Rehman, Coordinator, Hany Ghattas, Coordinator, Apoorva Vishwanath, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.